![](https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2022/earnings_image_1844.jpeg)
Amedisys (NASDAQ:AMED) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Amedisys reported in-line EPS of $1.18 versus an estimate of $1.18.
Revenue was up $8.61 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.17 which was followed by a 2.16% increase in the share price the next day.
Here's a look at Amedisys's past performance:
Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
---|---|---|---|---|
EPS Estimate | 1.36 | 1.67 | 1.43 | 1.47 |
EPS Actual | 1.53 | 1.69 | 1.54 | 1.49 |
Revenue Estimate | 568.37M | 566.19M | 544.86M | 553.37M |
Revenue Actual | 553.49M | 564.17M | 537.14M | 550.71M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.